These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Angiotensin converting enzyme-angiotensin II system, atherosclerosis, and angiotensin-converting enzyme inhibitors]. Aronov DM Ter Arkh; 2000; 72(12):5-7. PubMed ID: 11201833 [No Abstract] [Full Text] [Related]
27. [Effects of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): double-blind randomized trial]. Gnecchi M; Ardissino D Ital Heart J Suppl; 2001 Sep; 2(9):1027-8. PubMed ID: 11675825 [No Abstract] [Full Text] [Related]
28. Current trials on angiotensin-converting enzyme inhibitors and endothelial dysfunction. Anderson T Can J Cardiol; 1998 Jul; 14 Suppl D():33D-34D. PubMed ID: 9713430 [TBL] [Abstract][Full Text] [Related]
30. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function. Izzo JL Heart Dis; 2000; 2(5):380-3. PubMed ID: 11728286 [TBL] [Abstract][Full Text] [Related]
31. Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function? Fox K; Ferrari R; Yusuf S; Borer JS Eur Heart J; 2006 Sep; 27(18):2154-7. PubMed ID: 16905555 [TBL] [Abstract][Full Text] [Related]
32. Clinical restenosis trials: a perspective from the pharmaceutical industry. Uprichard AC; Texter M; Canter D Circulation; 1992 Apr; 85(4):1636-7. PubMed ID: 1555305 [No Abstract] [Full Text] [Related]
33. Endothelial dysfunction: its pathogenic role in atherosclerosis and its reversal by ACE inhibition. Neutel JM Postgrad Med; 2000 Oct; 108(5 Suppl):4-11. PubMed ID: 19667535 [TBL] [Abstract][Full Text] [Related]
34. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors. Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661 [TBL] [Abstract][Full Text] [Related]
37. Renin-angiotensin system and atherothrombotic disease: from genes to treatment. Jacoby DS; Rader DJ Arch Intern Med; 2003 May; 163(10):1155-64. PubMed ID: 12767951 [TBL] [Abstract][Full Text] [Related]
38. [Comparative study of the effect of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study]. Eleuteri E Ital Heart J Suppl; 2000 Jun; 1(6):830-1. PubMed ID: 11204017 [No Abstract] [Full Text] [Related]
39. Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function. Ray JG Can J Cardiol; 1997 Aug; 13(8):780-1, 783. PubMed ID: 9284846 [No Abstract] [Full Text] [Related]
40. Quinapril--a new angiotensin-converting enzyme inhibitor: an overview. Dzau VI Angiology; 1989 Apr; 40(4 Pt 2):329-30. PubMed ID: 2705641 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]